AVROBIO INC's ticker is AVRO and the CUSIP is 05455M100. A total of 50 filers reported holding AVROBIO INC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,655 | +58.0% | 1,725,089 | -2.5% | 0.01% | +57.1% |
| Q2 2023 | $1,680 | -5.0% | 1,770,147 | 0.0% | 0.01% | -12.5% |
| Q1 2023 | $1,768 | +69.0% | 1,770,147 | +20.4% | 0.01% | +60.0% |
| Q4 2022 | $1,046 | -99.9% | 1,469,892 | +24.4% | 0.01% | +25.0% |
| Q3 2022 | $758,000 | -26.6% | 1,181,757 | +5.2% | 0.00% | -20.0% |
| Q2 2022 | $1,033,000 | -14.2% | 1,123,564 | +23.0% | 0.01% | 0.0% |
| Q1 2022 | $1,204,000 | -10.3% | 913,457 | +161.8% | 0.01% | 0.0% |
| Q4 2021 | $1,343,000 | +445.9% | 348,953 | +686.9% | 0.01% | +400.0% |
| Q3 2021 | $246,000 | – | 44,344 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SV Health Investors, LLC | 2,736,027 | $45,555,000 | 28.05% |
| Aisling Capital Management LP | 736,998 | $12,271,000 | 12.93% |
| Cormorant Asset Management, LP | 1,357,784 | $22,607,000 | 1.84% |
| New Leaf Venture Partners, L.L.C. | 215,550 | $3,589,000 | 0.98% |
| Eventide Asset Management | 928,891 | $14,901,000 | 0.66% |
| EMERALD ADVISERS, LLC | 380,636 | $6,338,000 | 0.31% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 372,865 | $6,208,000 | 0.29% |
| Blackstone Inc. | 2,962,325 | $49,323,000 | 0.28% |
| PFM Health Sciences, LP | 241,413 | $4,020,000 | 0.11% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 143,762 | $2,394,000 | 0.10% |